MarginsXMarginsX
Home › Markets › RAJAF

TFA Therapeutics, Inc. (RAJAF)

RAJAF is quoted over the counter, not listed on an exchange. TFA Therapeutics, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · July 9, 2025
$9.18
No trades since Jul 9, 2025; later closes repeat the last quote
1-year return
0.0%
Market cap
No trades since Jul 9, 2025, so the close is not a market price and no cap
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerRAJAF, quoted over the counter
SEC CIK0001885680
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressTaipei City

Warning signs

Cash runway
1.1 months
$3K cash at December 31, 2025
Share count, 1 year
0.0%
2024-12-31 to 2025-12-31 · 0.0% over 3 years
Going-concern doubt
Yes
20-F filed May 15, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors among others raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time."
20-F 2026-05-15
Cash and burn$3K cash; operating cash flow -$9K a quarter.Report 2025-12-31
Shares outstanding111,120,000 (2025-12-31); 111,120,000 a year earlier; 111,120,000 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorYCM CPA INC., Irvine, California, United StatesPCAOB Form AP 2026-06-14
Late filings, 12 months1 NT noticeNT 20-F 2026-04-30
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$1.2M-$155K-$36K$3K$4.5M$1.2M20-F 2026-05-15
FY 2024
2024-12-31
$1.3M-$226K$312K$37K$4.3M$1.3M20-F 2026-05-15
FY 2023
2023-12-31
$883K$752K$360K$23K$431K$883K20-F 2026-05-15
FY 2022
2022-12-31
$53K-$720K-$321K$7K$471K$53K20-F/A 2025-09-23
FY 2021
2021-12-31
$879K-$491K-$365K$100K$1.1M$879K20-F 2023-05-15

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42023-03-30
Latest annual report20-F2026-05-15
Latest quarterly / interim6-K2026-09-02

Source: SEC EDGAR submissions feed, 38 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier